Huaier Granule in Treating Women With Triple Negative Breast Cancer

Inclusion Criteria

• •Age: ≥ 18 and ≤ 75 years, female;
• •Triple negative breast cancer has been surgically removed;
• •The triple negative breast cancer has been confirmed by pathological examination and Immunohistochemistry (IHC);
• •Not receiving any preoperative anticancer drugs;
• •The liver and kidney function satisfies the following conditions within 3 days after surgery (excluding day 3): aspartate aminotransferase (AST), glutamic-oxalacetic transaminase (ALT) \< 2 upper limit of normal (ULN), total bilirubin ≤ 1.5 ULN, serum creatinine \< 1.5 ULN;
• •Other laboratory tests meet the following requirements within 3 days after surgery (excluding day 3): Hb ≥ 90g/l, platelet count ≥ 100×109/L, absolute neutrophil count \> 1.5×109/L;
• •The expected survival time ≥ 6 months;
• •The subjects volunteer to sign the informed consent.